(2R,3S)-3-((tert-Butoxycarbonyl)amino)-2-hydroxy-5-methylhexanoic acid is a chiral, non-proteinogenic amino acid derivative. It features a β-hydroxy-α-amino acid scaffold with a tert-butoxycarbonyl (Boc) protecting group on the amine and an isobutyl side chain. The compound is characterized by its specific (2R,3S) stereochemistry, which is crucial for its biological activity and synthetic utility. This compound serves as a key chiral building block in the synthesis of complex bioactive molecules, particularly in peptide and peptidomimetic chemistry. Its primary application is as a critical intermediate in the synthesis of HIV protease inhibitors, such as Atazanavir and Darunavir. The β-hydroxy-α-amino acid structure mimics the transition state of peptide bond hydrolysis, making it an essential component for designing potent enzyme inhibitors. The Boc-protected amine and free carboxylic acid provide orthogonal handles for further peptide coupling and chain elongation. As a high-value synthetic intermediate, it is typically produced via asymmetric synthesis or enzymatic resolution to achieve the required enantiomeric purity. Its use is predominantly confined to advanced pharmaceutical research and development for the production of antiviral therapeutics.